Clinical Trial: A Pharmacokinetics (PK) Study in Healthy Adults
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Blepharoptosis
Study Type: INTERVENTIONAL
Official Title: A Multiple-Dose Pharmacokinetics (PK) Study of STN1013800 in Healthy Adults
Brief Summary:
This is to characterize STN1013800 active ingredient bioavailability following multiple-dose ocular administration of STN1013800 to both eyes in healthy adults.It is a PK study with screening period of up to 28 days + dosing period of 7 days + Follow-up period of 2 days.At present, there are no medicines for the treatment of acquired blepharoptosis in China.Therefore, efficacy and safety phase III study is also currently being conducted.
Read more